Results 31 to 40 of about 345,762 (276)
Background Mycoplasma pneumoniae respiratory infections are transmitted by aerosol and droplets in close contact. Aim We investigated global M. pneumoniae incidence after implementation of non-pharmaceutical interventions (NPIs) against COVID-19 in March
P. M. Meyer Sauteur +15 more
semanticscholar +1 more source
The History of Mycoplasma pneumoniae Pneumonia [PDF]
In the United States in the 1930s, although the pathogen was not known, atypical pneumonia was clinically distinguished from pneumococcal pneumonia by its resistance to sulfonamides. Reimann (1938) reported seven patients with an unusual form of tracheo bronchopneumonia and severe constitutional symptoms.
openaire +3 more sources
Interaction between alveolar macrophages and epithelial cells during Mycoplasma pneumoniae infection
Mycoplasma pneumoniae, as one of the most common pathogens, usually causes upper respiratory tract infections and pneumonia in humans and animals. It accounts for 10% to 40% of community-acquired pneumonia in children. The alveolar epithelial cells (AECs)
Ya-Zhi Xue, Mengyao Wang, Hong-Bing Han
semanticscholar +1 more source
Motility of Mycoplasma pneumoniae [PDF]
Cell of Mycoplasma pneumoniae FH gliding on a glass surface in liquid medium were examined by microscopic observation and quantitatively by microcinematography (30 frames per min). Comparisons were made only within the individual experiments. The cells moved in an irregular pattern with numerous narrow bends and circles.
U, Radestock, W, Bredt
openaire +2 more sources
Respiratory mycoplasmosis in pediatrician's practice
Respiratory mycoplasmosis is a group of infectious and inflammatory diseases of the respiratory system caused by pathogenic microorganisms - Mycoplasma species. It was found that the major causative agent is Mycoplasma pneumoniae (M. pneumoniae).
A. L. Zaplatnikov +2 more
doaj +1 more source
Background and Objective. Mycoplasma pneumoniae (MP) and Chlamydia pneumoniae (CP) infections are becoming increasingly prominent in respiratory infections.
Liuyang Hu +4 more
doaj +1 more source
Mycoplasma pneumoniae Infections: Pathogenesis and Vaccine Development
Mycoplasma pneumoniae is a major causative agent of community-acquired pneumonia which can lead to both acute upper and lower respiratory tract inflammation, and extrapulmonary syndromes. Refractory pneumonia caused by M.
Zhu-Lin Jiang +4 more
semanticscholar +1 more source
The timing of azithromycin treatment is not associated with the clinical prognosis of childhood Mycoplasma pneumoniae pneumonia in high macrolide-resistant prevalence settings. [PDF]
Mycoplasma pneumoniae infection is a major cause of community-acquired pneumonia in children. We performed a retrospective study to evaluate the clinical impact of the timing of azithromycin treatment in children with Mycoplasma pneumoniae pneumonia in ...
Dehua Yang, Linghong Chen, Zhimin Chen
doaj +1 more source
The uncontrolled course of bronchial asthma (BA) in children and insufficient efficacy of standard therapy regimens may be due to underestimated infectious factors.
L. G. Gorina +4 more
doaj +1 more source
Objective Mycoplasma pneumoniae (M. pneumoniae) is an important pathogen of community acquired pneumonia. With the outbreak of coronavirus disease 2019 (COVID-19), the prevalence of some infectious respiratory diseases has varied.
Yuan Cheng +11 more
semanticscholar +1 more source

